CSIMarket
 


Regenerx Biopharmaceuticals inc   (RGRX)
Other Ticker:  
 
 

RGRX's Revenue Growth by Quarter and Year

Regenerx Biopharmaceuticals Inc 's Revenue results by quarter and year




RGRX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.02 0.02 0.02
III Quarter September - 0.02 0.02 0.02
II Quarter June - 0.02 0.02 0.02
I Quarter March 0.02 0.02 0.02 0.02
FY   0.02 0.08 0.08 0.08



RGRX Revenue first quarter 2023 Y/Y Growth Comment
Regenerx Biopharmaceuticals Inc reported decrease in Revenue in the first quarter 2023 by -4.05% to $ 0.02 millions, from the same quarter in 2022.
The decrease in the first quarter 2023 Regenerx Biopharmaceuticals Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 2.06%.

Looking into first quarter 2023 results within Major Pharmaceutical Preparations industry 155 other companies have achieved higher Revenue growth. While Regenerx Biopharmaceuticals Inc ' s Revenue decline of -4.05% ranks overall at the positon no. 2456 in the first quarter 2023.




RGRX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 0 % 0 % 0 %
III Quarter September - 0 % 0 % 0 %
II Quarter June - 0 % 0 % 0 %
I Quarter March -4.05 % 0 % 0 % 0 %
FY   - 0 % 0 % 0 %

Financial Statements
Regenerx Biopharmaceuticals Inc 's first quarter 2023 Revenue $ 0.02 millions RGRX's Income Statement
Regenerx Biopharmaceuticals Inc 's first quarter 2022 Revenue $ 0.02 millions Quarterly RGRX's Income Statement
New: More RGRX's historic Revenue Growth >>


RGRX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 0 % 0 % 0 %
III Quarter September - 0 % 0 % 0 %
II Quarter June - 0 % 0 % 0 %
I Quarter March -4.05 % 0 % 0 % 0 %
FY (Year on Year)   - 0 % 0 % 0 %




Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #156
Healthcare Sector #409
Overall #2456

Revenue Y/Y Growth Statistics
High Average Low
154.12 % 2.06 % -100 %
(Jun 30 2016)   (Mar 31 2014)
Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #156
Healthcare Sector #409
Overall #2456
Revenue Y/Y Growth Statistics
High Average Low
154.12 % 2.06 % -100 %
(Jun 30 2016)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Regenerx Biopharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
446.33 % 7.49 % -100 %
(Mar 31 2016)  


RGRX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Regenerx Biopharmaceuticals Inc reported fall in Revenue from the fourth quarter by -4.05% to $ 0.02 millions, from $ 0.02 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 122 other companies have achieved higher Revenue quarter on quarter growth. While Regenerx Biopharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1880.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #123
Healthcare Sector #326
Overall #1880
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #123
Healthcare Sector #326
Overall #1880
Revenue Q/Q Growth Statistics
High Average Low
446.33 % 7.49 % -100 %
(Mar 31 2016)  


RGRX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Regenerx Biopharmaceuticals Inc reported fall in Revenue from the fourth quarter by -4.05% to $ 0.02 millions, from $ 0.02 millions released in the previous quarter.

Within Major Pharmaceutical Preparations industry 122 other companies have achieved higher Revenue quarter on quarter growth. While Regenerx Biopharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1880.


Regenerx Biopharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Revenue 12 Months Ending $ 0.08 $ 0.08 $ 0.08 $ 0.08 $ 0.08
Y / Y Revenue Growth (TTM) -0 % 0 % -0 % -0 % -0 %
Year on Year Revenue Growth Overall Ranking # 2278 # 2668 # 2222 # 2573 # 2587
Seqeuential Revenue Change (TTM) -0 % 0 % 0 % 0 % 0 %
Seq. Revenue Growth (TTM) Overall Ranking # 2658 # 2668 # 2340 # 2657 # 2516




Cumulative Revenue growth Comment
Regenerx Biopharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2022. If the fiscal year would end in Mar 31 2023, Regenerx Biopharmaceuticals Inc 's annual Revenue no change would be -0% year on year to $0 millions.

In the Healthcare sector 343 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2278, from total ranking in previous quarter at 2668.

Revenue TTM Q/Q Growth Statistics
High Average Low
53.94 %
2.58 %
-42.69 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 143
Healthcare Sector # 344
Overall # 2278

Revenue TTM Y/Y Growth Statistics
High Average Low
53.94 %
2.58 %
-42.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 143
Sector # 377
S&P 500 # 2658
Cumulative Revenue growth Comment
Regenerx Biopharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2022. If the fiscal year would end in Mar 31 2023, Regenerx Biopharmaceuticals Inc 's annual Revenue drop would be -0% year on year to $0 millions.

In the Healthcare sector 343 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2278, from total ranking in previous quarter at 2668.

Revenue TTM Q/Q Growth Statistics
High Average Low
53.94 %
2.58 %
-42.69 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 143
Healthcare Sector # 344
Overall # 2278

Revenue TTM Y/Y Growth Statistics
High Average Low
53.94 %
2.58 %
-42.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 143
Sector # 377
S&P 500 # 2658




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RGRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RGRX's Competitors
Revenue Growth for Regenerx Biopharmaceuticals Inc 's Suppliers
Revenue Growth for RGRX's Customers

You may also want to know
RGRX's Annual Growth Rates RGRX's Profitability Ratios RGRX's Asset Turnover Ratio RGRX's Dividend Growth
RGRX's Roe RGRX's Valuation Ratios RGRX's Financial Strength Ratios RGRX's Dividend Payout Ratio
RGRX's Roa RGRX's Inventory Turnover Ratio RGRX's Growth Rates RGRX's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2023
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Community Health Systems Inc -0.10%$ -0.096 millions
West Pharmaceutical Services Inc -0.47%$ -0.472 millions
Avalon Globocare Corp -0.49%$ -0.493 millions
Qhslab Inc -0.71%$ -0.712 millions
Dariohealth Corp -0.86%$ -0.856 millions
Acorda Therapeutics Inc -1.22%$ -1.225 millions
Baxter International Inc -1.56%$ -1.565 millions
Kymera Therapeutics Inc -1.62%$ -1.621 millions
Nature s Sunshine Products inc -1.68%$ -1.683 millions
Organon and Co -1.85%$ -1.851 millions
Scientific Industries Inc -2.08%$ -2.077 millions
Amgen Inc -2.13%$ -2.132 millions
Healthcare Services Group Inc -2.24%$ -2.245 millions
Orgenesis Inc -2.33%$ -2.329 millions
Adaptive Biotechnologies Corporation-2.52%$ -2.519 millions
Bristol myers Squibb Company-2.67%$ -2.670 millions
Caredx Inc -2.71%$ -2.712 millions
Biogen Inc -2.72%$ -2.717 millions
Innovage Holding Corp -2.72%$ -2.718 millions
Cardiff Lexington Corporation-2.73%$ -2.727 millions
Apyx Medical Corporation-2.81%$ -2.810 millions
Avanos Medical Inc -2.89%$ -2.888 millions
Align Technology inc -3.09%$ -3.090 millions
Laboratory Corporation Of America Holdings-3.12%$ -3.121 millions
Bio rad Laboratories Inc -3.32%$ -3.317 millions
National Healthcare Corp-3.38%$ -3.377 millions
Thermogenesis Holdings Inc -3.42%$ -3.417 millions
Gilead Sciences Inc -3.61%$ -3.612 millions
Arrowhead Pharmaceuticals Inc -3.65%$ -3.648 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com